27 May 2026
‘Interception’ drug trials hope to stop lung cancer before it starts.
You have full access to this article via your institution.
Globally, lung cancer kills more people than breast, prostate and blood cancers combined, but now researchers think that they might have developed a pill that prevents it. In this film, Nature explores the rapidly developing field of cancer interception. Cutting-edge research is showing an essential link between inflammation and cancer, which a global team of researchers says offers up a tantalizing opportunity. The scientists think that a blood test paired with relatively simple anti-inflammatory drugs could be all that is needed to detect those at risk and prevent lung cancer from ever developing.
doi: https://doi.org/10.1038/d41586-026-01382-2This article is part of Nature Outlook: Lung cancer, a supplement produced with financial support from Daiichi Sankyo and MSD. Nature maintains full independence in all editorial decisions related to the content. About this content.
